Human sex differences in d-amphetamine self-administration

Addiction

Volumn 105, Issue 4, 2010, Pages 727-731

  Vansickel, Andrea R ^a,b   Stoops, William W ^b   Rush, Craig R ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

D Amphetamine; Gender; Humans; Progressive ratio; Self administration; Sex differences

Indexed keywords

CENTRAL STIMULANT AGENT; DEXAMPHETAMINE;

ADDICTION; ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD PRESSURE; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECT; DRUG SELF ADMINISTRATION; FEMALE; HEART RATE; HUMAN; MALE; MENSTRUAL CYCLE; PSYCHOLOGICAL ASPECT; REINFORCEMENT; RETROSPECTIVE STUDY; SEX DIFFERENCE;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BEHAVIOR, ADDICTIVE; BLOOD PRESSURE; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXTROAMPHETAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEART RATE; HUMANS; MALE; MENSTRUAL CYCLE; REINFORCEMENT SCHEDULE; RETROSPECTIVE STUDIES; SELF ADMINISTRATION; SEX FACTORS; YOUNG ADULT;

EID: 77949390316     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2009.02858.x     Document Type: Article

References (26)

1. Carroll M. E., Morgan A. D., Lynch W. J., Campbell U. C., Dess N. K. Intravenous cocaine and heroin self-administration in rats selectively bred for differential saccharin intake: phenotype and sex differences. Psychopharmacology 2002 161 : 304 313.
2. Festa E. D., Russo S. J., Gazi F. M., Niyomchai T., Kemen L. M., Lin S. et al. Sex differences in cocaine-induced behavioral responses, pharmacokinetics, and monoamine levels. Neuropharmacology 2004 46 : 672 687.
3. Lynch W. J., Carroll M. E. Sex differences in the acquisition of intravenously self-administered cocaine and heroin in rats. Psychopharmacology 1999 44 : 77 82.
4. Roth M. E., Carroll M. E. Sex differences in the escalation of intravenous cocaine intake following long- or short-access to cocaine self-administration. Pharmacol Biochem Behav 2004 78 : 199 207.
5. Lynch W. J., Taylor J. R. Sex differences in the behavioral effects of 24-h/day access to cocaine under a discrete trial procedure. Neuropsychopharmacology 2004 29 : 943 951.
6. Chait L. D. Factors influencing the reinforcing and subjective effects of ephedrine in humans. Psychopharmacology 1994 113 : 381 387.
7. Gabbay F. H. Variations in affect following amphetamine and placebo: markers of stimulant drug preferance. Exp Clin Psychopharmacol 2003 11 : 91 101.
8. Chait L. D. Factors influencing the reinforcing and subjective effects of d-amphetamine in humans. Behav Pharmacol 1993 4 : 191 199.
9. Chait L. D. Reinforcing and subjective effects of methylphenidate in humans. Behav Pharmacol 1994 5 : 281 288.
10. Evans S. M., Haney M., Fischman M., Foltin R. Limited sex differences in response to 'binge' smoked cocaine use in humans. Neuropsychopharmacology 1999 21 : 445 454.
11. Rush C. R., Essman W. D., Simpson C. A., Baker R. W. Reinforcing and subject-rated effects of methylphenidate and d-amphetamine in non-drug abusing humans. J Clin Psychopharmacol 2001 21 : 273 286.
12. Stoops W. W., Glaser P. E. A., Fillmore M. T., Rush C. R. Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans. J Psychopharmacol 2004 18 : 534 543.
13. Stoops W. W., Vansickel A. R., Lile J. A., Rush C. R. Acute d-amphetamine pretreatment does not alter stimulant self-administration in humans. Pharmacol Biochem Behav 2007 87 : 20 9.
14. Comer S. D., Collins E. D., Fischman M. W. Choice between money and intranasal heroin in morphine maintained humans. Behav Pharmacol 1997 8 : 677 690.
15. Comer S. D., Collins E. D., Wilson S. T., Donovan M. R., Foltin R. W., Fischman M. W. Effects of an alternative reinforcer on intravenous heroin self-administration by humans. Eur J Pharmacol 1998 345 : 13 26.
16. Comer S. D., Walker E. A., Collins E. D. Buprenorphine/naloxone reduces the reinforcing and subjective effects of heroin in heroin-dependent subjects. Psychopharmacology 2005 181 : 664 675.
17. Comer S. D., Sullivan M. A., Walker E. A. Comparison of intravenous buprenorphine and methadone self-administration by recently detoxified heroin-dependent individuals. J Pharmacol Exp Ther 2005 315 : 1320 1330.
18. Stoops W. W., Lile J. A., Fillmore M. T., Glaser P. E., Rush C. R. Reinforcing effects of methylphenidate: influence of dose and behavioral demands following drug administration. Psychopharmacology 2005 177 : 349 355.
19. Stoops W. W., Lile J. A., Fillmore M. T., Glaser P. E., Rush C. R. Reinforcing effects of modafinil: influence of dose and behavioral demands following drug administration. Psychopharmacology 2005 182 : 186 193.
20. Martin W. R., Sloan J. W., Sapira J. D., Jasinski D. R. Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine and methylphenidate in man. Clin Pharmacol Ther 1971 12 : 245 258.
21. Rush C. R., Stoops W. W., Hays L. R., Glaser P. E., Hays L. S. Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans. J Pharmacol Exp Ther 2003 306 : 195 204.
22. Sanko A. J., Huque M. F., Dubey S. D. Some comments on frequently used multiple endpoint adjustment methods in clinical trials. Stat Med 1997 16 : 2529 2542.
23. Simple Interactive Statistical Analysis (SISA). Available at:. http://www.quantitativeskills.com/sisa/calculations/bonfer.htm (accessed 12 May 2008).
24. Stoops W. W., Lile J. A., Robbins C. G., Martin C. A., Kelly T. H. The reinforcing, subject-rated, performance, and cardiovascular effects of d-amphetamine: influence of sensation-seeking status. Addict Behav 2007 32 : 1177 1188.
25. Stoops W. W. Reinforcing effects of stimulants in humans: sensitivity of progressive-ratio schedules. Exp Clin Psychopharmacol 2008 16 : 503 512.
26. Terner J. M., deWit H. Menstrual cycle phase and response to drugs of abuse in humans. Drug Alcohol Depend 2006 84 : 1 13.